Bay City Capital is a San Francisco-based venture capital firm founded by Fred Craves and John Diekman in 1997. The firm actively invests in life sciences sector.
Bay City Capital invests in multiple stages, namely debt, early stage venture, late-stage venture and private equity.
As of November 2019, the company invested in general life sciences, nutrition and agribusiness sector.
Timeline
1997
Founded
Invested in
Patents
Funding Rounds Participated In
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
May 11, 2020
BioSpace
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with high unmet medical need, is pleased to announce the appointment of Dr. Manuel López-Figueroa of Bay City Capital as an independent director.